Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury.

Xiaotong LouYuanyuan HuHong ZhangJia LiuYin Zhao

Published in: Journal of nanobiotechnology (2021)

The PDA nanoparticle-based therapeutic nanoplatform displayed excellent performance in ROS elimination, providing a promising probability for treating retinal degeneration diseases.

Keyphrases

optic nerve
optical coherence tomography
single cell
photodynamic therapy
cell therapy
dna damage
cell death
cancer therapy
reactive oxygen species
diabetic retinopathy
drug release
spinal cord injury
mesenchymal stem cells
neuropathic pain
spinal cord